Skip to main content

Advertisement

Log in

Late Recurrence of Low-Risk Stage II Colorectal Cancer Shortly After Etanercept

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Roh MS, Wang L, Oyedeji C, et al. Human Kupffer cells are cytotoxic against human colon adenocarcinoma. Surgery. 1990;108(2):400–5.

    CAS  PubMed  Google Scholar 

  2. Kopylov U, Vutcovici M, Kezouh A, Seidman E, Bitton A, Afif W. Risk of lymphoma, colorectal and skin cancer in patients with IBD treated with immunomodulators and biologics: a Quebec claims database study. Inflamm Bowel Dis. 2015;21(8):1847–53.

    Article  PubMed  Google Scholar 

  3. Mercer LK, Lunt M, Low AL, et al. Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis. 2015;74:1087.

    Article  PubMed  Google Scholar 

  4. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Colon cancer Version 3.2015. 2015 October 5; National Comprehensive Cancer Network. [available at http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf].

  5. Larmonier N, Cathelin D, Larmonier C, et al. The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Exp Cell Res. 2007;313(11):2345–55.

    Article  CAS  PubMed  Google Scholar 

  6. Heim ME, Siegmund R, Illiger HJ, et al. Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society. Onkologie. 1990;13(6):444–7.

    CAS  PubMed  Google Scholar 

  7. Schaadt M, Pfreundschuh M, Lorscheidt G, Peters KM, Steinmetz T, Diehl V. Phase II study of recombinant human tumor necrosis factor in colorectal carcinoma. J Biol Response Mod. 1990;9(2):247–50.

    CAS  PubMed  Google Scholar 

  8. Flores MB, Rocha GZ, Damas-Souza DM, et al. Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice. Gastroenterology. 2012;143(3):741–53.

    Article  CAS  PubMed  Google Scholar 

  9. van Grevenstein WM, Hofland LJ, van Rossen ME, van Koetsveld PM, Jeekel J, van Eijck CH. Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci. 2007;52(10):2775–83.

    Article  PubMed  Google Scholar 

  10. Stanilov N, Miteva L, Dobreva Z, Stanilova S. Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha. Biotechnol Biotechnol Equip. 2014;28(5):911–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Conflict of Interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tony Ibrahim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ibrahim, T., Saleh, K., Track-smayra, V. et al. Late Recurrence of Low-Risk Stage II Colorectal Cancer Shortly After Etanercept. J Gastrointest Canc 47, 506–508 (2016). https://doi.org/10.1007/s12029-015-9788-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-015-9788-y

Keywords

Navigation